Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
6
pubmed:dateCreated
2009-3-27
pubmed:abstractText
Recent work identifies the recruitment of alternate routes for carbohydrate oxidation, other than pyruvate dehydrogenase (PDH), in hypertrophied heart. Increased carboxylation of pyruvate via cytosolic malic enzyme (ME), producing malate, enables "anaplerotic" influx of carbon into the citric acid cycle. In addition to inefficient NADH production from pyruvate fueling this anaplerosis, ME also consumes NADPH necessary for lipogenesis. Thus, we tested the balance between PDH and ME fluxes in hypertrophied hearts and examined whether low triacylglyceride (TAG) was linked to ME-catalyzed anaplerosis. Sham-operated (SHAM) and aortic banded rat hearts (HYP) were perfused with buffer containing either 13C-palmitate plus glucose or (13)C glucose plus palmitate for 30 minutes. Hearts remained untreated or received dichloroacetate (DCA) to activate PDH and increase substrate competition with ME. HYP showed a 13% to 26% reduction in rate pressure product (RPP) and impaired dP/dt versus SHAM (P<0.05). DCA did not affect RPP but normalized dP/dt in HYP. HYP had elevated ME expression with a 90% elevation in anaplerosis over SHAM. Increasing competition from PDH reduced anaplerosis in HYP+DCA by 18%. Correspondingly, malate was 2.2-fold greater in HYP than SHAM but was lowered with PDH activation: HYP=1419+/-220 nmol/g dry weight; HYP+DCA=343+/-56 nmol/g dry weight. TAG content in HYP (9.7+/-0.7 micromol/g dry weight) was lower than SHAM (13.5+/-1.0 micromol/g dry weight). Interestingly, reduced anaplerosis in HYP+DCA corresponded with normalized TAG (14.9+/-0.6 micromol/g dry weight) and improved contractility. Thus, we have determined partial reversibility of increased anaplerosis in HYP. The findings suggest anaplerosis through NADPH-dependent, cytosolic ME limits TAG formation in hypertrophied hearts.
pubmed:grant
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/19213957, http://linkedlifedata.com/resource/pubmed/commentcorrection/19213957-10759602, http://linkedlifedata.com/resource/pubmed/commentcorrection/19213957-11028498, http://linkedlifedata.com/resource/pubmed/commentcorrection/19213957-11171606, http://linkedlifedata.com/resource/pubmed/commentcorrection/19213957-11922894, http://linkedlifedata.com/resource/pubmed/commentcorrection/19213957-11934668, http://linkedlifedata.com/resource/pubmed/commentcorrection/19213957-11988640, http://linkedlifedata.com/resource/pubmed/commentcorrection/19213957-12629214, http://linkedlifedata.com/resource/pubmed/commentcorrection/19213957-1390679, http://linkedlifedata.com/resource/pubmed/commentcorrection/19213957-14757696, http://linkedlifedata.com/resource/pubmed/commentcorrection/19213957-15271865, http://linkedlifedata.com/resource/pubmed/commentcorrection/19213957-15466668, http://linkedlifedata.com/resource/pubmed/commentcorrection/19213957-15522914, http://linkedlifedata.com/resource/pubmed/commentcorrection/19213957-15618539, http://linkedlifedata.com/resource/pubmed/commentcorrection/19213957-16234271, http://linkedlifedata.com/resource/pubmed/commentcorrection/19213957-16768833, http://linkedlifedata.com/resource/pubmed/commentcorrection/19213957-17229809, http://linkedlifedata.com/resource/pubmed/commentcorrection/19213957-17404155, http://linkedlifedata.com/resource/pubmed/commentcorrection/19213957-18155232, http://linkedlifedata.com/resource/pubmed/commentcorrection/19213957-19325159, http://linkedlifedata.com/resource/pubmed/commentcorrection/19213957-1978808, http://linkedlifedata.com/resource/pubmed/commentcorrection/19213957-3284880, http://linkedlifedata.com/resource/pubmed/commentcorrection/19213957-7396838, http://linkedlifedata.com/resource/pubmed/commentcorrection/19213957-8622576, http://linkedlifedata.com/resource/pubmed/commentcorrection/19213957-8762037, http://linkedlifedata.com/resource/pubmed/commentcorrection/19213957-8941110
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Mar
pubmed:issn
1524-4571
pubmed:author
pubmed:issnType
Electronic
pubmed:day
27
pubmed:volume
104
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
805-12
pubmed:dateRevised
2011-3-1
pubmed:meshHeading
pubmed:year
2009
pubmed:articleTitle
Substrate-enzyme competition attenuates upregulated anaplerotic flux through malic enzyme in hypertrophied rat heart and restores triacylglyceride content: attenuating upregulated anaplerosis in hypertrophy.
pubmed:affiliation
Department of Physiology and Biophysics, MC 901, UIC College of Medicine, 835 S Wolcott Ave, Chicago, IL 60612, USA. dougl@uic.edu
pubmed:publicationType
Journal Article, Research Support, N.I.H., Extramural